AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Beta Bionics, Inc. Common Stock
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG00JNGG9R1
19.16▼ 0.18 (-0.93%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
19.34
Day's Range
18.81 – 19.54
52-Week Range
8.80 – 32.71
Volume
809.2K
Avg Volume
1.3M
Share Statistics
Shares Outstanding
Employees
423
Exchange
XNAS
Listed
2025-01-30
Share count as of July 27, 2026

Beta Bionics, Inc. Common Stock (BBNX) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Beta Bionics, Inc. Common Stock (BBNX)
What is Beta Bionics, Inc. Common Stock's Market Cap?
Beta Bionics, Inc. Common Stock's Market Cap is $862.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Enterprise Value?
Beta Bionics, Inc. Common Stock's Enterprise Value is $681.6M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Price / Sales?
Beta Bionics, Inc. Common Stock's Price / Sales is 7.2×, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EV / Revenue?
Beta Bionics, Inc. Common Stock's EV / Revenue is 5.7×, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EV / EBITDA?
Beta Bionics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Revenue (TTM)?
Beta Bionics, Inc. Common Stock's Revenue (TTM) is $119.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Net Income (TTM)?
Beta Bionics, Inc. Common Stock's Net Income (TTM) is -$73.0M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EBITDA?
Beta Bionics, Inc. Common Stock's EBITDA is -$80.8M, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's Diluted EPS (TTM)?
Beta Bionics, Inc. Common Stock's Diluted EPS (TTM) is -1.62, based on as-reported figures from SEC (XBRL) filings.
What is Beta Bionics, Inc. Common Stock's EBITDA Margin?
Beta Bionics, Inc. Common Stock's EBITDA Margin is -67.9%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · BBNXAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024
Net sales
YoY growth+37.8%+56.6%+57.1%+63.1%
Cost of sales
Gross profit
% of revenue59.0%59.5%59.0%55.5%
Operating expenses:
Research and development
Sales and marketing
General and administrative
Total operating expenses
% of revenue138.9%147.4%109.2%118.0%
Loss from operations
% of revenue-79.9%-87.9%-50.2%-62.5%
Other income (expense):
Interest income
Other expense—
Change in fair value of warrant liabilities
Total other income (expense), net
Net loss
% of revenue-73.1%-79.3%-41.9%-52.1%
Net loss per share attributable to common stockholders, basic
Net loss per share attributable to common stockholders, diluted